BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24583258)

  • 1. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents.
    Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A
    Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling the stability and size of double-emulsion-templated poly(lactic-co-glycolic) acid microcapsules.
    Tu F; Lee D
    Langmuir; 2012 Jul; 28(26):9944-52. PubMed ID: 22667691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound degradation of novel polymer contrast agents.
    El-Sherif DM; Lathia JD; Le NT; Wheatley MA
    J Biomed Mater Res A; 2004 Jan; 68(1):71-8. PubMed ID: 14661251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation.
    Sun Y; Zheng Y; Ran H; Zhou Y; Shen H; Chen Y; Chen H; Krupka TM; Li A; Li P; Wang Z; Wang Z
    Biomaterials; 2012 Aug; 33(24):5854-64. PubMed ID: 22617321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
    Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.
    Wang CW; Yang SP; Hu H; Du J; Li FH
    Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
    Zheng J; Hornsby PJ
    Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Characterization of PLGA Shell Microcapsules Containing Aqueous Cores Prepared by Internal Phase Separation.
    Abulateefeh SR; Alkilany AM
    AAPS PharmSciTech; 2016 Aug; 17(4):891-7. PubMed ID: 26416284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
    Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
    J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of PLGA based nanoparticles for imaging guided applications.
    Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
    Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification.
    Wei Y; Wang Y; Wang L; Hao D; Ma G
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):399-408. PubMed ID: 21683559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uniform PEGylated PLGA Microcapsules with Embedded Fe3O4 Nanoparticles for US/MR Dual-Modality Imaging.
    Xu S; Yang F; Zhou X; Zhuang Y; Liu B; Mu Y; Wang X; Shen H; Zhi G; Wu D
    ACS Appl Mater Interfaces; 2015 Sep; 7(36):20460-8. PubMed ID: 26327472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of polymer end-chemistry on the morphology of perfluorohexane polymeric microcapsules intended as ultrasound contrast agents.
    Mousnier L; Huang N; Morvan E; Fattal E; Tsapis N
    Int J Pharm; 2014 Aug; 471(1-2):10-7. PubMed ID: 24836666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release.
    Della Porta G; Campardelli R; Cricchio V; Oliva F; Maffulli N; Reverchon E
    J Pharm Sci; 2016 Jul; 105(7):2164-72. PubMed ID: 27290629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign preparation of aqueous core poly lactic-co-glycolic acid (PLGA) microcapsules.
    Nomura T; Routh AF
    J Colloid Interface Sci; 2018 Mar; 513():1-9. PubMed ID: 29128617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA nanoparticles from nano-emulsion templating as imaging agents: Versatile technology to obtain nanoparticles loaded with fluorescent dyes.
    Fornaguera C; Feiner-Gracia N; Calderó G; García-Celma MJ; Solans C
    Colloids Surf B Biointerfaces; 2016 Nov; 147():201-209. PubMed ID: 27513588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents.
    Díaz-López R; Tsapis N; Libong D; Chaminade P; Connan C; Chehimi MM; Berti R; Taulier N; Urbach W; Nicolas V; Fattal E
    Biomaterials; 2009 Mar; 30(8):1462-72. PubMed ID: 19097640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual growth factor delivery using biocompatible core-shell microcapsules for angiogenesis.
    Choi DH; Subbiah R; Kim IH; Han DK; Park K
    Small; 2013 Oct; 9(20):3468-76. PubMed ID: 23585380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile fabrication of biocompatible PLGA drug-carrying microspheres by O/W pickering emulsions.
    Wei Z; Wang C; Liu H; Zou S; Tong Z
    Colloids Surf B Biointerfaces; 2012 Mar; 91():97-105. PubMed ID: 22088755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.
    Wheatley MA; Forsberg F; Oum K; Ro R; El-Sherif D
    Ultrasonics; 2006 Nov; 44(4):360-7. PubMed ID: 16730047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.